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Background: Ad hoc percutaneous coronary intervention (PCI) which performed
immediately after diagnostic catheterization has become the most common way of
coronary intervention. However, limited data is available on in-hospital and long-term
outcome comparing ad hoc and staged chronic total occlusion (CTO) PCI. Our aim of
the study was to ﬁgure the short-term and long-term outcome after ad hoc or staged
CTO PCI.
Methods: This retrospective analysis included consecutive 512 patients underwent
561 CTO PCI procedures between January 2002 and December 2009. Patient basic
demographics, lesion characteristics, interventional procedure, devices used and in-
hospital outcomes were compared between ad hoc and staged CTO PCI groups. 3-year
clinical outcomes included all-cause mortality, cardiac mortality, myocardial infarc-
tion (MI), the need for coronary artery bypass graft surgery (CABG), major adverse
cardiac events (MACE) and target vessel revascularization (TVR) were compared.
Time-to-event analyses were performed using Kaplan-Meier statistics.
Results: Four hundred and ﬁfty-one patients (80.4%) were enrolled in ad hoc CTO
PCI group. Final successful revascularization was higher in ad hoc CTO PCI group
compared with staged CTO PCI group (82.9 vs. 77.3%, p¼0.17) without statistical
signiﬁcance. There was no signiﬁcant difference between ad hoc CTO PCI and staged
CTO PCI groups in in-hospital outcomes such as all-cause mortality, cardiac death,
myocardial infarction, urgent bypass surgery, urgent PCI or complications. Patients
with ad hoc CTO PCI had lower rate of all-cause mortality (6.2% vs. 6.5%, p¼0.89),
the need for CABG (1.9% vs. 2.1%, p¼0.89) but higher rate of cardiac mortality
(1.7% vs. 0.0%, p¼0.21), MI (1.0% vs. 0.0%, p¼0.34), MACE (24.1% vs. 17.5%,
p¼0.19) and TVR (17.8% vs. 10.0%, p¼0.069) without statistical signiﬁcance in
3-year clinical outcomes.
Conclusion: 3-year clinical outcomes compared with ad hoc CTO PCI and staged
CTO PCI had insigniﬁcant differences between: all-cause mortality, cardiac mortality,
MI, the need for CABG, MACE and TVR.Congenital Heart Disease
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Background: Long-term clinical outcome after transcatheter closure of atrial septal
defect (ASD) in adults remains unknown, especially in geriatric population. The aim
of this study was to clarify the clinical implication of transcatheter closure of ASD
among the different patient population over than 55 years of age.
Methods: A total of 212 patients over than 55 years of age who underwent transcatheter
closure of ASD were enrolled. Patients were divided into 3 groups according to age at
the procedure (55-64 years: n¼ 89, 65-74 years: n¼ 72,75 years: n¼ 51). Cardiac or
non-cardiac events and the changes of NewYork Heart Association functional class and
hemodynamic parameters after the procedure were reviewed in each group.
Results: As shown in ﬁgure, Kaplan-Meier analysis revealed that the age at the proce-
dure did not inﬂuence on all-cause mortality (log-rank test, P ¼ 0.385) and cardiovas-
cular mortality (log-rank test, P¼ 0.938). Additionally, major events including all-cause
mortality and hospitalization due to heart failure or stroke were not different among the
3 different age groups at least 5 years follow-up period (log-rank test, P¼ 0.208). Even
in patients aged 75 years, the improvements in New York Heart Association
functional class (2.1 0.7 to 1.5 0.6, P<0.001) and right ventricular / left ventricular
end-diastolic diameter ratio (0.99  0.23 to 0.75  0.13, P <0.001) were observed
after the procedure, similar to the improvements in other 2 younger aged groups.
Conclusion: Although further long-term clinical outcomes are still unknown, our
ﬁndings demonstrated that the clinical implication of this procedure is reliable even in
geriatric population.S16 JACC Vol 63/12/Suppl S j ATCTAP A-055
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Background: In recent years, ASD(atrial septal defect, ASD) occlusion has been
widely promoted in China and also has achieved a great progress. However, it is
sometimes a tough job in the treatment of MASD(multiple atrial septal defects,pril 22–25, 2014 j TCTAP Abstracts/ORAL/Congenital Heart Disease
